.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Argus Health
Deloitte
Colorcon
US Army
Novartis
Express Scripts
Federal Trade Commission
Cipla
US Department of Justice

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089651

« Back to Dashboard
NDA 089651 describes LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, which is a drug marketed by Belmora Llc, West-ward Pharms Int, Hospira, Eastman Kodak, and Empi, and is included in thirteen NDAs. It is available from six suppliers. Additional details are available on the LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE profile page.

The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

Summary for NDA: 089651

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 089651

Suppliers and Packaging for NDA: 089651

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION 089651 ANDA Hospira, Inc. 0409-3183 0409-3183-01 5 VIAL, SINGLE-DOSE in 1 CARTON (0409-3183-01) > 20 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.005MG/ML;2%
Approval Date:Jun 21, 1988TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Cerilliant
QuintilesIMS
Fish and Richardson
AstraZeneca
Federal Trade Commission
Dow
Julphar
Harvard Business School
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot